BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,975,286
- Total 13F shares
- 178,061,150
- Share change
- +2,744,277
- Total reported value
- $15,246,971,937
- Put/Call ratio
- 140%
- Price per share
- $85.65
- Number of holders
- 471
- Value change
- +$229,169,981
- Number of buys
- 222
- Number of sells
- 226
Quarterly Holders Quick Answers
What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09061G101:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
9.2%
|
17,749,061
|
$1,576,649,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
15,709,874
|
$1,395,509,000 | — | 31 Mar 2019 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
7.4%
|
14,190,873
|
$1,260,575,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.6%
|
12,663,369
|
$1,124,888,000 | — | 31 Mar 2019 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
6.4%
|
12,412,593
|
$1,102,611,000 | — | 31 Mar 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.9%
|
7,589,294
|
$674,157,000 | — | 31 Mar 2019 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3%
|
5,881,446
|
$522,449,000 | — | 31 Mar 2019 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
2.7%
|
5,128,909
|
$455,601,000 | — | 31 Mar 2019 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.6%
|
5,005,318
|
$444,622,000 | — | 31 Mar 2019 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
4,636,152
|
$411,829,000 | — | 31 Mar 2019 | |
| Invesco Ltd. |
13F
|
Company |
1.8%
|
3,468,122
|
$308,073,000 | — | 31 Mar 2019 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.4%
|
2,653,174
|
$235,598,000 | — | 31 Mar 2019 | |
| Palo Alto Investors LP |
13F
|
Company |
1.4%
|
2,641,485
|
$234,643,000 | — | 31 Mar 2019 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.3%
|
2,523,973
|
$224,205,000 | — | 31 Mar 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
2,481,541
|
$220,435,000 | — | 31 Mar 2019 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
1.2%
|
2,372,712
|
$210,768,000 | — | 31 Mar 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
2,175,566
|
$193,256,000 | — | 31 Mar 2019 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.1%
|
2,040,932
|
$181,296,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.99%
|
1,907,224
|
$169,417,000 | — | 31 Mar 2019 | |
| Capital International Investors |
13F
|
Company |
0.92%
|
1,776,819
|
$157,835,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.91%
|
1,754,082
|
$155,688,000 | — | 31 Mar 2019 | |
| Capital World Investors |
13F
|
Company |
0.81%
|
1,554,027
|
$138,044,000 | — | 31 Mar 2019 | |
| NORGES BANK |
13F
|
Company |
0.77%
|
1,480,818
|
$131,541,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.76%
|
1,463,941
|
$130,043,000 | — | 31 Mar 2019 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.75%
|
1,452,668
|
$129,041,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.72%
|
1,392,772
|
$123,710,000 | — | 31 Mar 2019 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.71%
|
1,362,755
|
$121,054,000 | — | 31 Mar 2019 | |
| FMR LLC |
13F
|
Company |
0.68%
|
1,321,066
|
$117,350,000 | — | 31 Mar 2019 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.65%
|
1,261,908
|
$112,095,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.62%
|
1,202,314
|
$106,801,000 | — | 31 Mar 2019 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.61%
|
1,168,364
|
$103,785,775 | — | 31 Mar 2019 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.6%
|
1,160,946
|
$103,126,000 | — | 31 Mar 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.58%
|
1,128,648
|
$100,258,000 | — | 31 Mar 2019 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.58%
|
1,120,000
|
$99,490,000 | — | 31 Mar 2019 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.56%
|
1,087,011
|
$96,559,000 | — | 31 Mar 2019 | |
| HIGHLINE CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.55%
|
1,066,249
|
$94,715,000 | — | 31 Mar 2019 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.55%
|
1,054,338
|
$93,657,000 | — | 31 Mar 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0.49%
|
954,799
|
$84,814,000 | — | 31 Mar 2019 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.49%
|
947,677
|
$84,183,000 | — | 31 Mar 2019 | |
| Manning & Napier Group, LLC |
13F
|
Company |
0.47%
|
910,959
|
$80,919,000 | — | 31 Mar 2019 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.47%
|
909,552
|
$80,796,000 | — | 31 Mar 2019 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.46%
|
879,474
|
$78,124,000 | — | 31 Mar 2019 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.44%
|
857,556
|
$76,177,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.44%
|
850,430
|
$75,541,000 | — | 31 Mar 2019 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.42%
|
804,252
|
$71,442,000 | — | 31 Mar 2019 | |
| TCW GROUP INC |
13F
|
Company |
0.41%
|
787,734
|
$69,975,000 | — | 31 Mar 2019 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.39%
|
744,952
|
$66,174,000 | — | 31 Mar 2019 | |
| USS Investment Management Ltd |
13F
|
Company |
0.38%
|
735,000
|
$65,253,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.37%
|
720,219
|
$63,977,000 | — | 31 Mar 2019 | |
| NATIXIS |
13F
|
Company |
0.35%
|
672,311
|
$59,036,000 | — | 31 Mar 2019 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q2 2019
As of 30 Jun 2019,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
471 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
178,061,150 shares.
The largest 10 holders included
Capital Research Global Investors, VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, Clearbridge Investments, LLC, SANDS CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and NUVEEN ASSET MANAGEMENT, LLC.
This page lists
472
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
475
Q2 2019 holders
471
Holder diff
-4
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.